GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with ...

A case-control study revealed that combinations of drugs for cardiovascular diseases and hypertension were frequently prescribed before a diagnosis of bullous pemphigoid (BP), but the risk associated ...

New research shows GLP-1 drugs may cut heart failure and cardiovascular risks in high‑risk patients, even as Medicare delays a pilot program to expand coverage for weight‑loss use. Observational ...